Binding Studies of LH in Benign and Malignant Uterine Tumors Homogenate with ^I25 I-Anti LH Antibody.

The sera levels of luteinizing hormone were investigated prior to, surgery in 10 postmenopausal women with benign and 10 postmenopausal women with malignant uterine tumors. The sera concentrations of LH were compared with those of 10 healthy postmenopausal age matched controls. Student s T-test analysis revealed that there is no significant decrease of serum LH levels in benign tumor and malignant uterine tumor